Biotech Stocks Underperform on Political Concerns (IBB)

Biotechnology stocks declined 2% Tuesday amid concerns that renewed talks between Manchin and Schumer could eventually lead to a bill with drug price control provisions.

• Johnson & Johnson (NYSE: JNJ) -2.2%
• Bristol-Myers Squibb (NYSE: BMY) -2%
• Eli Lilly & Co. (NYSE: LLY) -3.3%
• Pfizer (NYSE: PFE) -2.8%
• AbbVie (NYSE: ABBV) -1.3%
• Amgen (NASDAQ: AMGN) -1.4%
• Regeneron (NASDAQ: REGN) -4%
• iShares Nasdaq Biotechnology (NASDAQ: IBB) declined 2%

You May Also Be Interested In

• Apple In Discussions To Buy Memory Chips From Chinese Companies - Bloomberg
• Sec Probes Alleged Insider Options Trades That Hit Susquehanna - Bloomberg
• Michael Burry Says He Shorted Caterpillar For The First Time - Bloomberg